posted
its hasent stalled that is the last real trade and that is good as no one is selling here and this will get its new legs which means a new HOD and break that .0025 wall soon
-------------------- please dont trade stocks on my alerts, do your dd first. Posts: 5265 | From: Alberta | Registered: Jan 2006
| IP: Logged |
posted
LBTN Incase You Guys Didn't See It...Lifeline Biotechnologies, Inc. (OTC:LBTN), Tuesday, the shares closed down $0.0002 to close at $0.0012. The volume was 9,061,494. The Company recently announced that the Company is providing additional OvaScope(TM) equipment for the continuation of patient testing, under the direction of Professor Kefah Mokbel, in the United Kingdom. The OvaScope is a microendoscope that has been designed by the Company to assist in the early detection of ovarian cancer. Lifeline previously announced the Company's successful initial testing of the OvaScope(TM) in surgical procedures. The Company plans to continue testing with the objective of obtaining CE certification and clearance to initially market the OvaScope(TM) in the International Medical Markets. Upon successful completion patient testing The Company will submit testing results to the FDA and seek clearance for marketing the device in the United States. According to the Center for Disease Control (CDC) website, there are approximately 25,600 cases of ovarian cancers detected in the US each year. The unfortunate fact is that there is no FDA approved method for the early detection of ovarian cancer that is available to the medical community today. Consequently, ovarian cancer is not usually detected until the very late stages of the disease and at a time when treatments are less successful with only a 30% survival rate.
"The initial product testing has been successfully completed involving ten female patients in a gynecological oncology unit. The OvaScope(TM) identified all patients with peritoneal disease. The results were very encouraging, and we have expectations that we will achieve similar results in our second round of testing," stated Jim Holmes, Lifeline's CEO.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's Cancer Detection technologies deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care. The MastaScope(TM) is used to assist in the early detection of cancer and other abnormalities of the breast. The MastaScope(TM) has completed development and has entered the marketplace, internationally. The First Warning System(TM) for assisting in the early detection of breast cancer, and the OvaScope(TM) for assisting in the early detection of ovarian cancer, are continuing to be developed by the company. More information is available at the company's website: www.lbtn.com.Posts: 70 | From: Ohio | Registered: Nov 2005
| IP: Logged |
posted
LBTN Incase You Guys Didn't See It...Lifeline Biotechnologies, Inc. (OTC:LBTN), The Company recently announced that the Company is providing additional OvaScope(TM) equipment for the continuation of patient testing, under the direction of Professor Kefah Mokbel, in the United Kingdom. The OvaScope is a microendoscope that has been designed by the Company to assist in the early detection of ovarian cancer. Lifeline previously announced the Company's successful initial testing of the OvaScope(TM) in surgical procedures. The Company plans to continue testing with the objective of obtaining CE certification and clearance to initially market the OvaScope(TM) in the International Medical Markets. Upon successful completion patient testing The Company will submit testing results to the FDA and seek clearance for marketing the device in the United States. According to the Center for Disease Control (CDC) website, there are approximately 25,600 cases of ovarian cancers detected in the US each year. The unfortunate fact is that there is no FDA approved method for the early detection of ovarian cancer that is available to the medical community today. Consequently, ovarian cancer is not usually detected until the very late stages of the disease and at a time when treatments are less successful with only a 30% survival rate.
"The initial product testing has been successfully completed involving ten female patients in a gynecological oncology unit. The OvaScope(TM) identified all patients with peritoneal disease. The results were very encouraging, and we have expectations that we will achieve similar results in our second round of testing," stated Jim Holmes, Lifeline's CEO.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's Cancer Detection technologies deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care. The MastaScope(TM) is used to assist in the early detection of cancer and other abnormalities of the breast. The MastaScope(TM) has completed development and has entered the marketplace, internationally. The First Warning System(TM) for assisting in the early detection of breast cancer, and the OvaScope(TM) for assisting in the early detection of ovarian cancer, are continuing to be developed by the company. More information is available at the company's website: www.lbtn.com.
-------------------- please dont trade stocks on my alerts, do your dd first. Posts: 5265 | From: Alberta | Registered: Jan 2006
| IP: Logged |
posted
well rocked if people bid whck i really cant do anything...i personally think it will run and am still holding all my shares and i am in at 17 i could of sold at 23 but i do believe this will run
-------------------- please dont trade stocks on my alerts, do your dd first. Posts: 5265 | From: Alberta | Registered: Jan 2006
| IP: Logged |